Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2 positive gastric (GC) and esophagogastric junction cancer (EGJC): First results of the EORTC 1203 INNOVATION study, in collaboration with the Korean Cancer Study Group, and the Dutch Upper GI Cancer group
JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. H. 16. 2023
Erscheinungsjahr: 2023
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Wagner, Anna Dorothea (Autor)
Grabsch, Heike I. (Autor)
Mauer, Murielle (Autor)
Romario, Uberto Fumagalli (Autor)
Kang, Yoon-Koo (Autor)
Bouche, Olivier (Autor)
Lorenzen, Sylvie (Autor)
Moehler, Markus H. (Autor)
Thuss-Patience, Peter C. (Autor)
Elme, Anneli (Autor)
Folprecht, Gunnar (Autor)
Martens, Uwe Marc (Autor)
Smith, Denis Michel (Autor)
Guzman, Maria del Carmen Galan (Autor)
Ducreux, Michel Pierre (Autor)
Garcia, Marc D. Prime Iez (Autor)
Piessen, Guillaume (Autor)
Rha, Sun Young (Autor)
Collienne, Maike (Autor)
Lordick, Florian (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
